VISHEE(SH:688580)2026-02-26 07:50Financial Performance - Total revenue for 2025 reached CNY 462.73 million, a year-on-year increase of 15.66%[3] - Operating profit was CNY 150.56 million, reflecting a 35.03% increase compared to the previous year[3] - Net profit attributable to shareholders was CNY 136.63 million, up 33.99% year-on-year[3] - Net profit excluding non-recurring gains and losses increased by 44.97% to CNY 120.49 million[3] - Basic earnings per share rose to CNY 1.43, an increase of 33.64%[3] Assets and Equity - Total assets at the end of the reporting period were CNY 1,907.40 million, a 4.78% increase from the beginning of the period[3] - Shareholders' equity attributable to the parent company was CNY 1,691.61 million, up 3.94%[3] Business Strategy and Growth - The company enhanced its product competitiveness and marketing system, leading to steady business growth[6] - Core products, including transcranial magnetic stimulators and pelvic floor RF robots, saw significant sales growth and improved market penetration[6] - The company plans to strengthen core product competitiveness and accelerate overseas market entry while promoting sustainable growth[6]